Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a simple drink rebuild strength after a hip fracture?

NCT ID NCT07780006

Symptom relief Sponsor: Thammasat University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 21, 2026 · Last updated Aug 21, 2026

Summary

This trial tests whether a daily protein-rich nutritional drink, containing HMB, calcium, and vitamin D, can help older adults regain muscle strength after hip fracture surgery. Participants aged 65 and older will receive either the supplement or standard care for 30 days. Researchers will measure grip strength, mobility, and daily function over 12 weeks to see if the supplement improves recovery.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Oral nutritional supplement containing protein, calcium, vitamin D, and HMB (Ensure Advance Plus)
What this could lead to
If effective, this supplement could speed up muscle strength recovery and improve independence in older adults after hip fracture surgery.
What could go wrong
This is a small, early-stage trial, and results may not apply to all patients. The supplement may not significantly improve outcomes over standard care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 60 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Oct 2026

An estimate. Start dates often move.

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

65 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Femoral neck fracture patients undergoing hip arthroplasty (Total hip arthroplasty or bipolar hemiarthroplasty) * Age ≥ 65 years * American Society of Anesthesiologists (ASA) class I-III * Participants understand and consent to the protocol of the trial Exclusion Criteria: * Pathologic fracture or high impact fracture * Morbid obesity (Body mass index \> 40) * Chronic kidney disease (Chronic kidney disease stage \> 3b or estimated glomerular filtration rate (eGFR) \< 30) * Thyroid disease or endrocrinopathy * Gastrointestinal intolerance preventing oral supplementation or Malabsorption syndromes * Malignancy with radiotherapy or chemotherapy * Cognitive disorder * Decompensated Liver Disease or Cirrhosis Child-Pugh Class B-C * Known allergy/intolerance to milk or other supplement ingredients

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Femoral neck fractures are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

femoral neck fracture hip fracture

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Femoral neck fractures Geriatric hip fracture Hip fracture, post surgery recovery, muscle resilience

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Thammasat University

    Pathum Thani, 12120, Thailand

More trials for these conditions

Other studies related to the condition(s) this trial covers.